Mirae Asset Global Etfs Holdings Ltd. Nuvectis Pharma, Inc. Call Options Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVCT
# of Institutions
50Shares Held
3.21MCall Options Held
44.5KPut Options Held
50.1K-
Vanguard Group Inc Valley Forge, PA667KShares$4.01 Million0.0% of portfolio
-
Ronit Capital LLP563KShares$3.38 Million5.37% of portfolio
-
Iridian Asset Management LLC373KShares$2.24 Million1.01% of portfolio
-
Baldwin Brothers LLC350KShares$2.11 Million0.19% of portfolio
-
Geode Capital Management, LLC Boston, MA285KShares$1.71 Million0.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $88M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...